Click here to get full coverage on BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed? - simplywall.st

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed?  simplywall.st

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX  MarketBeat

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat

Click here to get full coverage on BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Nasdaq

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?  Nasdaq

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Nasdaq

Click here to get full coverage on BioNTech (BNTX) soars 11.8%: Is further upside left in the stock? - MSN

BioNTech (BNTX) soars 11.8%: Is further upside left in the stock?  MSN

BioNTech (BNTX) soars 11.8%: Is further upside left in the stock? - MSN

Click here to get full coverage on BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss - Sahm

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss  Sahm

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss - Sahm

Click here to get full coverage on BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness - Yahoo Finance

BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness  Yahoo Finance

BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness - Yahoo Finance

Click here to get full coverage on BNTX Stock Today: January 23 momentum after six-month high, 2026 catalysts - Meyka

BNTX Stock Today: January 23 momentum after six-month high, 2026 catalysts  Meyka

BNTX Stock Today: January 23 momentum after six-month high, 2026 catalysts - Meyka

Click here to get full coverage on Understanding the Setup: (BNTX) and Scalable Risk - Stock Traders Daily

Understanding the Setup: (BNTX) and Scalable Risk  Stock Traders Daily

Understanding the Setup: (BNTX) and Scalable Risk - Stock Traders Daily

Click here to get full coverage on BioNTech SE (BNTX) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews

BioNTech SE (BNTX) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth  DirectorsTalk Interviews

BioNTech SE (BNTX) Stock Analysis: Exploring a 27% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews

Click here to get full coverage on BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why - MarketBeat

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why  MarketBeat

BioNTech (NASDAQ:BNTX) Trading 7.5% Higher - Here's Why - MarketBeat

Click here to get full coverage on What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders - Yahoo Finance

What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders  Yahoo Finance

What BioNTech (BNTX)'s 90%+ COVID Vaccine Efficacy Signal Means For Shareholders - Yahoo Finance

Click here to get full coverage on BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss - simplywall.st

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss  simplywall.st

BioNTech (BNTX) Valuation Check After Recent Share Price Momentum And Ongoing Net Loss - simplywall.st

Click here to get full coverage on BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank - MarketBeat

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank  MarketBeat

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Berenberg Bank - MarketBeat

Click here to get full coverage on BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street - Yahoo Finance

BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street  Yahoo Finance

BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street - Yahoo Finance

Click here to get full coverage on BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts  MarketBeat

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Click here to get full coverage on BioNTech (BNTX): Assessing Valuation as Investor Sentiment Shifts After Recent Pipeline Developments - Yahoo Finance

BioNTech (BNTX): Assessing Valuation as Investor Sentiment Shifts After Recent Pipeline Developments  Yahoo Finance

BioNTech (BNTX): Assessing Valuation as Investor Sentiment Shifts After Recent Pipeline Developments - Yahoo Finance

Click here to get full coverage on BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion - simplywall.st

BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion  simplywall.st

BioNTech (BNTX) Is Up 7.3% After Unveiling Ambitious Late-Stage Oncology Pipeline Expansion - simplywall.st

Click here to get full coverage on BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift - Yahoo Finance

BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift  Yahoo Finance

BioNTech (BNTX): Assessing Valuation Following Recent Momentum Shift - Yahoo Finance

Click here to get full coverage on A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update - simplywall.st

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update  simplywall.st

A Look At BioNTech (BNTX) Valuation After Expanded Oncology Pipeline Update - simplywall.st

Click here to get full coverage on BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments - Yahoo Finance

BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments  Yahoo Finance

BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments - Yahoo Finance

Click here to get full coverage on BNTX shares rise on Goldman Sachs upgrade, optimism for cancer portfolio - MSN

BNTX shares rise on Goldman Sachs upgrade, optimism for cancer portfolio  MSN

BNTX shares rise on Goldman Sachs upgrade, optimism for cancer portfolio - MSN

Click here to get full coverage on Institutions Own 22% of BioNTech SE (NASDAQ:BNTX) Shares but Private Equity Firms Control 41% of the Company - 富途资讯

Institutions Own 22% of BioNTech SE (NASDAQ:BNTX) Shares but Private Equity Firms Control 41% of the Company  富途资讯

Institutions Own 22% of BioNTech SE (NASDAQ:BNTX) Shares but Private Equity Firms Control 41% of the Company - 富途资讯

Click here to get full coverage on BMO Capital Maintains a Buy on BioNTech SE (BNTX) - Yahoo Finance

BMO Capital Maintains a Buy on BioNTech SE (BNTX)  Yahoo Finance

BMO Capital Maintains a Buy on BioNTech SE (BNTX) - Yahoo Finance

Click here to get full coverage on Goldman Sachs Upgrade Sparks Optimism Around BioNTech Stock - timothysykes.com

Goldman Sachs Upgrade Sparks Optimism Around BioNTech Stock  timothysykes.com

Goldman Sachs Upgrade Sparks Optimism Around BioNTech Stock - timothysykes.com

Click here to get full coverage on BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration - Yahoo Finance

BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration  Yahoo Finance

BioNTech (BNTX) Is Up 7.9% After Raising 2025 Revenue Guidance on Bristol-Myers Collaboration - Yahoo Finance

Click here to get full coverage on BioNTech’s Strategic Focus Spurs Stock Optimism​ - StocksToTrade

BioNTech’s Strategic Focus Spurs Stock Optimism​  StocksToTrade

BioNTech’s Strategic Focus Spurs Stock Optimism​ - StocksToTrade

Click here to get full coverage on Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? - Barchart.com

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?  Barchart.com

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? - Barchart.com

Click here to get full coverage on A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement - Yahoo Finance

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement  Yahoo Finance

A Look at BioNTech (NasdaqGS:BNTX) Valuation Following Pfizer’s Share Sale Announcement - Yahoo Finance

Click here to get full coverage on BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions - simplywall.st

BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions  simplywall.st

BioNTech (BNTX) Is Up 5.1% After 90%-Effective COVID Data Raises New Franchise Questions - simplywall.st

Click here to get full coverage on Goldman Sachs Boosts BioNTech’s Prospects in Oncology - timothysykes.com

Goldman Sachs Boosts BioNTech’s Prospects in Oncology  timothysykes.com

Goldman Sachs Boosts BioNTech’s Prospects in Oncology - timothysykes.com

Click here to get full coverage on BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal - Yahoo Finance

BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal  Yahoo Finance

BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal - Yahoo Finance

Click here to get full coverage on The Technical Signals Behind (BNTX) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (BNTX) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (BNTX) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. - Yahoo Finance

BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V.  Yahoo Finance

BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. - Yahoo Finance

Click here to get full coverage on Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm - Yahoo Finance

Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm  Yahoo Finance

Recent Agreements Set To Bolster BioNTech SE (BNTX)’s Oncology Arm - Yahoo Finance

Click here to get full coverage on Seven big cancer studies BioNTech will report on in 2026 - Stock Titan

Seven big cancer studies BioNTech will report on in 2026  Stock Titan

Seven big cancer studies BioNTech will report on in 2026 - Stock Titan

Click here to get full coverage on BioNTech (Nasdaq: BNTX) maps 2026 pipeline milestones and COVID shift - Stock Titan

BioNTech (Nasdaq: BNTX) maps 2026 pipeline milestones and COVID shift  Stock Titan

BioNTech (Nasdaq: BNTX) maps 2026 pipeline milestones and COVID shift - Stock Titan

Click here to get full coverage on Could BioNTech's (BNTX) AI Ambitions Shift the Balance Between Innovation and Ownership Influence? - Yahoo Finance

Could BioNTech's (BNTX) AI Ambitions Shift the Balance Between Innovation and Ownership Influence?  Yahoo Finance

Could BioNTech's (BNTX) AI Ambitions Shift the Balance Between Innovation and Ownership Influence? - Yahoo Finance

Click here to get full coverage on Goldman Sachs Upgrades BioNTech (BNTX) to Buy, Raises Price Target to $142 - Intellectia AI

Goldman Sachs Upgrades BioNTech (BNTX) to Buy, Raises Price Target to $142  Intellectia AI

Goldman Sachs Upgrades BioNTech (BNTX) to Buy, Raises Price Target to $142 - Intellectia AI

Click here to get full coverage on Will BioNTech's (BNTX) Latest R&D Day Reveal a Shift in Its Innovation Ambitions? - Yahoo Finance

Will BioNTech's (BNTX) Latest R&D Day Reveal a Shift in Its Innovation Ambitions?  Yahoo Finance

Will BioNTech's (BNTX) Latest R&D Day Reveal a Shift in Its Innovation Ambitions? - Yahoo Finance

Click here to get full coverage on Goldman Sachs Upgrades BioNTech (BNTX) to 'Buy' with Increased P - GuruFocus

Goldman Sachs Upgrades BioNTech (BNTX) to 'Buy' with Increased P  GuruFocus

Goldman Sachs Upgrades BioNTech (BNTX) to 'Buy' with Increased P - GuruFocus

Click here to get full coverage on BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... - Yahoo Finance

BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...  Yahoo Finance

BioNTech SE (BNTX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... - Yahoo Finance

Click here to get full coverage on BIONTECH SE Earnings Results: $BNTX Reports Quarterly Earnings - Quiver Quantitative

BIONTECH SE Earnings Results: $BNTX Reports Quarterly Earnings  Quiver Quantitative

BIONTECH SE Earnings Results: $BNTX Reports Quarterly Earnings - Quiver Quantitative

Click here to get full coverage on Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year?  Yahoo Finance

Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Click here to get full coverage on BioNTech (NASDAQ: BNTX) reports €1,518.9M revenue, net loss €28.7M; raises FY outlook - Stock Titan

BioNTech (NASDAQ: BNTX) reports €1,518.9M revenue, net loss €28.7M; raises FY outlook  Stock Titan

BioNTech (NASDAQ: BNTX) reports €1,518.9M revenue, net loss €28.7M; raises FY outlook - Stock Titan

Click here to get full coverage on BioNTech (BNTX) Concludes Successful Stock Offering - GuruFocus

BioNTech (BNTX) Concludes Successful Stock Offering  GuruFocus

BioNTech (BNTX) Concludes Successful Stock Offering - GuruFocus

Click here to get full coverage on BioNTech (BNTX) Losses Worsen 22.1% Annually, Challenging Bullish Valuation Narratives - Yahoo Finance

BioNTech (BNTX) Losses Worsen 22.1% Annually, Challenging Bullish Valuation Narratives  Yahoo Finance

BioNTech (BNTX) Losses Worsen 22.1% Annually, Challenging Bullish Valuation Narratives - Yahoo Finance

Click here to get full coverage on BioNTech (NasdaqGS:BNTX): Exploring Valuation After a Year of Lower Share Price and Mixed Results - Yahoo Finance

BioNTech (NasdaqGS:BNTX): Exploring Valuation After a Year of Lower Share Price and Mixed Results  Yahoo Finance

BioNTech (NasdaqGS:BNTX): Exploring Valuation After a Year of Lower Share Price and Mixed Results - Yahoo Finance

Click here to get full coverage on Why BioNTech Stock Crushed the Market Today - The Motley Fool

Why BioNTech Stock Crushed the Market Today  The Motley Fool

Why BioNTech Stock Crushed the Market Today - The Motley Fool

Click here to get full coverage on SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat

SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX  MarketBeat

SG Americas Securities LLC Sells 69,726 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat

Click here to get full coverage on BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term - Yahoo Finance

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term  Yahoo Finance

BioNTech SE (BNTX): Among the Best Growth Stocks to Buy and Hold for the Long Term - Yahoo Finance

Click here to get full coverage on BioNTech (BNTX) Stock: More Uncertainty Emerges - Seeking Alpha

BioNTech (BNTX) Stock: More Uncertainty Emerges  Seeking Alpha

BioNTech (BNTX) Stock: More Uncertainty Emerges - Seeking Alpha

Click here to get full coverage on Why BioNTech Stock Sank by More Than 7% Today - The Motley Fool

Why BioNTech Stock Sank by More Than 7% Today  The Motley Fool

Why BioNTech Stock Sank by More Than 7% Today - The Motley Fool

Click here to get full coverage on BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance

BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates  Yahoo Finance

BioNTech SE (NASDAQ:BNTX) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance

Click here to get full coverage on Two early mRNA firms join forces as BioNTech buys CureVac - Stock Titan

Two early mRNA firms join forces as BioNTech buys CureVac  Stock Titan

Two early mRNA firms join forces as BioNTech buys CureVac - Stock Titan

Click here to get full coverage on BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart - Seeking Alpha

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart  Seeking Alpha

BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 Gotistobart - Seeking Alpha

Click here to get full coverage on MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today - TipRanks

MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today  TipRanks

MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today - TipRanks

Click here to get full coverage on BioNtech Stock Forecast 2025–2030 | Future Outlook - Capital.com

BioNtech Stock Forecast 2025–2030 | Future Outlook  Capital.com

BioNtech Stock Forecast 2025–2030 | Future Outlook - Capital.com

Click here to get full coverage on BioNTech SE to Announce Third Quarter 2025 Financial Results and Host Investor Call on November 3, 2025 - Quiver Quantitative

BioNTech SE to Announce Third Quarter 2025 Financial Results and Host Investor Call on November 3, 2025  Quiver Quantitative

BioNTech SE to Announce Third Quarter 2025 Financial Results and Host Investor Call on November 3, 2025 - Quiver Quantitative

Click here to get full coverage on Why BioNTech (BNTX) Stock Is Moving Today - GuruFocus

Why BioNTech (BNTX) Stock Is Moving Today  GuruFocus

Why BioNTech (BNTX) Stock Is Moving Today - GuruFocus

Click here to get full coverage on BioNTech SE Sponsored ADR $BNTX Shares Sold by TB Alternative Assets Ltd. - MarketBeat

BioNTech SE Sponsored ADR $BNTX Shares Sold by TB Alternative Assets Ltd.  MarketBeat

BioNTech SE Sponsored ADR $BNTX Shares Sold by TB Alternative Assets Ltd. - MarketBeat

Click here to get full coverage on BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold (BNTX) - Seeking Alpha

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold (BNTX)  Seeking Alpha

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold (BNTX) - Seeking Alpha

Click here to get full coverage on BioNTech (NASDAQ: BNTX) schedules Nov. 3, 2025 webcast and call to discuss results - Stock Titan

BioNTech (NASDAQ: BNTX) schedules Nov. 3, 2025 webcast and call to discuss results  Stock Titan

BioNTech (NASDAQ: BNTX) schedules Nov. 3, 2025 webcast and call to discuss results - Stock Titan

Click here to get full coverage on Does BioNTech (NASDAQ:BNTX) Have A Healthy Balance Sheet? - simplywall.st

Does BioNTech (NASDAQ:BNTX) Have A Healthy Balance Sheet?  simplywall.st

Does BioNTech (NASDAQ:BNTX) Have A Healthy Balance Sheet? - simplywall.st

Click here to get full coverage on BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206 - TipRanks

BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206  TipRanks

BMY and BNTX Advance New Immunotherapy Bet in First-Line Liver Cancer With ROSETTA HCC-206 - TipRanks

Click here to get full coverage on Trading Systems Reacting to (BNTX) Volatility - Stock Traders Daily

Trading Systems Reacting to (BNTX) Volatility  Stock Traders Daily

Trading Systems Reacting to (BNTX) Volatility - Stock Traders Daily

Click here to get full coverage on BioNTech (BNTX) Net Losses Rise 22.1% Annually, Challenging Bullish Pipeline Narratives - simplywall.st

BioNTech (BNTX) Net Losses Rise 22.1% Annually, Challenging Bullish Pipeline Narratives  simplywall.st

BioNTech (BNTX) Net Losses Rise 22.1% Annually, Challenging Bullish Pipeline Narratives - simplywall.st

Click here to get full coverage on BioNTech (BNTX) Shares Decline by Nearly 10% - GuruFocus

BioNTech (BNTX) Shares Decline by Nearly 10%  GuruFocus

BNTX

Price Chart

Key Statistics

Technicals

About BNTX

Latest News

BioNTech (BNTX) Is Up 6.4% After Expanding Late-Stage Oncology Pipeline Ambitions - Has The Bull Case Changed? - simplywall.st

Baillie Gifford & Co. Lowers Position in BioNTech SE Sponsored ADR $BNTX - MarketBeat

BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? - Nasdaq

Advanced Charts

Top Gainers

Top Losers